The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at ...
Lenacapavir is an injectable medicine that only needs to be taken twice a year, making it easier to use than daily HIV pills.
The Department of Health said the decision reflects its mandate to ensure that all citizens have access to safe, effective, ...
The South African on MSN
The HIV-prevention jab is here: What you need to know…
You can now be vaccinated against HIV – but that does not mean you can be reckless, warns the Department of Health ...
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the delivery of first shipments of lenacapavir – Gilead’s twice-yearly ...
Scientists at MIT have identified 24 protein fragments that could form a new tuberculosis vaccine, offering a potential ...
"Eligible patients in Northern Ireland may receive this treatment," says the Department of Health The post Injectable PrEP ...
The search for long-COVID treatments echoes the previous struggles against HIV/AIDS. Now researchers are taking lessons from ...
15don MSNOpinion
HIV knows no borders, and the Trump administration's new strategy leaves Americans vulnerable, expert explains
Protecting public health abroad benefits Americans. In a globalized world, diseases and their social and economic impacts do ...
Women are disproportionately affected by HIV, making up nearly half of new infections globally and in India. Stigma, gender ...
Gilead Sciences, Inc. (NASDAQ: GILD) today announced positive topline results from the Phase 3 ARTISTRY-1 trial. The ...
The Trump administration’s new global HIV prevention strategy prioritizes preventing mother-to-child HIV transmission. About 120,000 children under the age of 5 were newly infected with HIV in 2024, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results